Status:
COMPLETED
Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia
Lead Sponsor:
AstraZeneca
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Brief Summary
This is a single-arm, phase IV, open-label, prospective, non interventional study in approximately 600 patients that will be followed for 6 months in order to evaluate the safety and efficacy of queti...
Eligibility Criteria
Inclusion
- Diagnosis of schizophrenia at least 1 year prior to screening
- Inadequate response or poor safety /tolerability or non-compliance to previous antipsychotic medication
- Provision of Informed Consent prior to enrolment
Exclusion
- Known hypersensitivity to active substance of excipients
- Patients receiving P450 3A4 inhibitors
- Pregnancy or lactation
- Substance abuse or dependence
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
576 Patients enrolled
Trial Details
Trial ID
NCT00690365
Start Date
June 1 2007
End Date
April 1 2008
Last Update
December 9 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.